Abhijit Lele &Amp; Sohini Das

Stories by Abhijit Lele &Amp; Sohini Das

Nearly 33% of India's medical devices capacity lying unused

Nearly 33% of India's medical devices capacity lying unused

Rediff.com   7 Dec 2021

After ramping up production to meet the steep demand spike during the Covid-19 pandemic, Indian medical device makers are now struggling with idle capacity. According to industry estimates, around a third of the installed capacity, especially for consumables, disposables, small-ticket electronic items, etc., is lying unutilised. Sample this: India used to produce just 6.24 million pieces of PPE kits per annum before the pandemic, but by June this was ramped up to 233.87 million pieces per annum.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com   7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

Another Anil Ambani firm in big trouble

Another Anil Ambani firm in big trouble

Rediff.com   2 Dec 2021

Reliance Power (RPower) has defaulted on payment of interest worth Rs 1.17 crore to DBS Bank India and Rs 44 lakh to IDBI Bank. It failed to pay up interest on October 30, 2021. The firm, part of the Anil Ambani-promoted Reliance group, in filing with BSE, said it has term loans and working capital arrangements with three lenders - YES Bank, IDBI Bank and DBS. Its stock closed 1.41 per cent lower at Rs 12.6 per share on the BSE on December 1. About exposure of YES Bank, there is a 'standstill' applicable till December 26, 2021.

10 mn unused Covid vaccine doses lying with private hospitals

10 mn unused Covid vaccine doses lying with private hospitals

Rediff.com   1 Dec 2021

With around 2 million Covid vaccine doses likely to get wasted in December, leading hospital chains have now started to give it gratis to citizens. Sohini Das and Ruchika Chitravanshi report.

Bad-loan market may soon see flurry of activities

Bad-loan market may soon see flurry of activities

Rediff.com   29 Nov 2021

Banks are set to sell dud-loans worth Rs 90,000 crore of 22 firms in the first tranche to the National Asset Reconstruction Company (NARCL). It's reason for cheer given that such sales to asset reconstruction companies (ARCs) have been poor in recent times. In fiscal 2020, their assets under management (AUM) contracted by 4 per cent; and in fiscal 2021, it fell by another 100 basis points to Rs 1.07 trillion. So, why are we where we are?

Nasal vaccine booster dose may be used with Covaxin

Nasal vaccine booster dose may be used with Covaxin

Rediff.com   27 Nov 2021

A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.

'Definite improvement in economic activity in October'

'Definite improvement in economic activity in October'

Rediff.com   24 Nov 2021

'I hope the trend is sustainable and that economic activity accelerates going forward.'

8 banks recast exposures worth Rs 27,000 cr in OTR 2.0

8 banks recast exposures worth Rs 27,000 cr in OTR 2.0

Rediff.com   2 Nov 2021

Personal loans have about 80 per cent share in exposures restructured under regulatory package 2.0 by eight banks who have declared results for the second quarter. The remaining 20 per cent are loans to individuals used for business and credit to MSMEs. The total recast exposure of these banks under One Time Restructuring (OTR 2.0) was Rs 27,708 crore.

Dish TV vs Yes Bank: Another corporate battle looms

Dish TV vs Yes Bank: Another corporate battle looms

Rediff.com   18 Oct 2021

Even as the corporate battle over Zee Entertainment Enterprises (ZEEL) has reached the Bombay high court, another Essel Group firm - Dish TV India - is gearing up for a legal battle with YES Bank by planning to move the National Company Law Tribunal to appoint six of its nominees on the board of the loss-making company. While Dish TV said YES Bank has acquired 26 per cent stake by invoking the pledged shares of Essel Group promoter, it also said YES Bank must make an open offer to shareholders of the company, according to the Securities and Exchange Board of India (Sebi) takeover code. This, as YES Bank is seeking to take control of the company, said Dish TV.

Focus on second dose as India inches closer to 1 billion jabs

Focus on second dose as India inches closer to 1 billion jabs

Rediff.com   18 Oct 2021

Experts, however, feel that given the intensity of the second wave and the high single dose coverage, India is in a good position to avoid any drastic wave in the near future.

States, Centre not on same page on digital health mission

States, Centre not on same page on digital health mission

Rediff.com   14 Oct 2021

Tamil Nadu plans parallel programme with unique user IDs

Will syringe shortage puncture India's Covid vaccine plans?

Will syringe shortage puncture India's Covid vaccine plans?

Rediff.com   14 Oct 2021

Will syringe shortage puncture India's Covid vaccine plans?

Superseding boards of two Srei cos won't roil markets

Superseding boards of two Srei cos won't roil markets

Rediff.com   13 Oct 2021

Superseding the boards of two non-banking financial companies (NBFCs) in the Srei group will neither create liquidity challenges for sound entities, nor build systemic crises because the markets have factored in the problems with the Kolkata-based firms. Such regulatory steps will help in making the NBFC space more robust, bankers and market experts said. The action should have begun earlier because the Reserve Bank of India (RBI) had done a special audit last financial year and asked the group to make provisions for assets considered stressed, analysts said.

India's digital health mission likely to face privacy issues

India's digital health mission likely to face privacy issues

Rediff.com   11 Oct 2021

Lack of clarity on data-sharing persists, public health experts sceptic about the pilot that was run in six Union territories as benchmark for national roll-out

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com   30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

SBI ready to support Tata group's bid for Air India

SBI ready to support Tata group's bid for Air India

Rediff.com   28 Sep 2021

India's largest public sector bank State Bank of India (SBI) will support Tata group's bid for soon-to-be-privatised Air India by subscribing to Tata Sons debentures or funding the special purpose vehicle (SPV) set up by Tata Sons for the acquisition. Bankers said the credit rating of Tata group's holding company is "AAA" signifying high safety and a combination of Air India with its existing airline businesses would make it a formidable player - leading to a duopoly market with IndiGo. It would also open many business opportunities, including in the retail segment, an official said.

Depositors of 21 stressed co-op banks to get Rs 5 lakh by Nov

Depositors of 21 stressed co-op banks to get Rs 5 lakh by Nov

Rediff.com   23 Sep 2021

The Deposit Insurance and Credit Guarantee Corporation (DICGC) will pay the depositors of 21 stressed cooperative banks, including the Punjab & Maharashtra Co-Operative Bank (PMC Bank), up to Rs 5 lakh within 90 days. The Reserve Bank of India (RBI) had imposed restrictions on the withdrawal of deposits from these banks. Of the 21 banks, 11 are from Maharashtra, five from Karnataka, and one each from Uttar Pradesh, Kerala, Rajasthan, Madhya Pradesh, and Punjab.

Mystery fever in wake of falling Covid cases raises alarm

Mystery fever in wake of falling Covid cases raises alarm

Rediff.com   20 Sep 2021

The sudden spike in cases of fever in India has claimed over 100 lives in five states, including UP, MP, Bihar, Haryana, and West Bengal. In UP, Firozabad and Mathura alone have reported 72 cases.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com   17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Covid Vaccine: Syringe manufacturers are ramping up

Covid Vaccine: Syringe manufacturers are ramping up

Rediff.com   15 Sep 2021

The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.